The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Clopidogrel Polling Results for CLASS IIa Guidelines

Any recommendations found on these pages are for education use only. Wikidoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, Wikidoc suggests that the following classification scheme be used. Read more about the classification scheme used by the ACC / AHA Guidelines Committee here.

Class IIa Guidelines
1. Long-term maintenance therapy (e.g., 1 year) with clopidogrel (75 mg per day orally) is reasonable in STEMI patients regardless of whether they undergo reperfusion with fibrinolytic therapy or do not receive reperfusion therapy. Class II a (Level of Evidence: C)

 Antiplatelet Agents / Anticoagulants Therapy for STEMI: Clopidogrel CLASS IIa Recommendation should be: CLASS I CLASS IIa CLASS IIb CLASS III